Navigation Links
Cardium Announces Commercial Development of Excellagen(TM) a Customized Collagen-Based Topical Gel for Initial Use as an Adjunct to Surgical Debridement in Patients With Diabetic Foot Ulcers
Date:10/14/2009

healing diabetic ulcers.

Cardium Orthobiologics Initiative

Cardium recently announced its plans to develop a DNA-based orthobiologics product portfolio based on research and development that will initially focus on non-union bone fractures for medically-compromised patients, and spinal fusions for patients with degenerative disc disease. Orthobiologics is a rapidly growing segment of the orthopedics market and represents biologically-active products designed to enhance musculo-skeletal repair and regeneration. The initial orthobiologics focus will be on the development of Osteorate(TM), a DNA-based non-surgical injectable bone graft gel to repair bone fractures and regenerate tissue in certain medically-compromised patient populations. Osteorate will be based on a reformulation of the Excellarate wound healing product candidate. The Gene Activated Matrix technology allows for a broad spectrum of formulations which would include, but not be limited to, collagen, demineralized bone matrices, allograft and synthetic graft materials.

In addition, Cardium recently announced the results of preclinical research published in the scientific journal, Gene Therapy, demonstrating the potential benefits of its Gene Activated Matrix technology for accelerating and enhancing periodontal tissue repair and oral implant osseointegration. This research further supports Cardium's decision to expand the Company's focus of its regenerative medicine technologies to include the emerging new high growth market segment of orthobiologics.

About Cardium

Cardium is focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses that have the potential to address significant unmet medical needs and definable pathways to commercialization, partnering and other economic monetizations. Cardium's investment portfolio includes the Tissue Repair Company and Cardium Biologics, medi
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Scientific Journal Gene Therapy Reports That Cardiums Gene Activated Matrix Technology Accelerates Periodontal Tissue Regeneration
2. Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments
3. Cardium Completes Sale of InnerCool Therapies Business to Royal Philips Electronics
4. Cardium Receives Preliminary Notification of Inclusion in the Russell 3000(R) Index and Russell Global(R) Index
5. Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting
6. Cardium Reports on First Quarter 2009 Financial Results and Recent Developments
7. Cardium Reports on New Excellarate(TM) Product Formulations to Expand Commercialization Potential Into Multiple Wound Healing Applications
8. Cardium Provides Update Regarding Exchange Listing Compliance Plan Accepted by NYSE Amex
9. Cardiums InnerCool Announces Journal of Neurotrauma Highlights Hypothermia Therapys Role in Post Cardiac Arrest, and Traumatic Brain and Spinal Cord Injury Patients
10. Cardium Reports on Recent Highlights, Financial Results and 2009 Outlook
11. Cardiums Exchange Listing Compliance Plan Accepted by NYSE Alternext US
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... As reported by the Frederick News Post in the article ... graduate of the Frederick County Drug Treatment Court has found a ... program. The graduate, Korey Shorb, put together a race called Run ... plans to donate the proceeds of the event to the program ... Shorb, who graduated in 2008, admitted that he would probably be ...
(Date:8/29/2014)... 29, 2014 Formed in 2014, KAJ Brothers ... beyond their years. Their sophisticated Pop/R&B sound, with beautiful ... is fortunate enough to experience every day. , ... uplifted and feeling loved with the primary purpose of elevating ... this, the group unanimously replied - “To make chivalry cool ...
(Date:8/29/2014)... Angeles, CA (PRWEB) August 29, 2014 Dr. ... with late stages of hair loss achieve great results in ... the Facial Hair Transplant , an FUE method that ... recipient area. This method lets patients whose hair loss ... head. Facial Hair Transplant is a great alternative for those ...
(Date:8/29/2014)... Charleston, SC (PRWEB) August 29, 2014 Highly regarded ... special reports on important hearing health topics. The four reports are ... The Secrets to Hearing Aid Success , ... Aid , Understanding Auditory Processing Disorder in Children ... 4 topics because there is a lot of confusion and misinformation ...
(Date:8/29/2014)... Pursuing its deepest desires to help ... a stunning new design that promises to redefine the ... notable surrogacy platform has witnessed a 42 percent increase ... a month, the FindSurrogateMother.com community is formed by hopeful ... goal — the precious gift of life. , Whether ...
Breaking Medicine News(10 mins):Health News:Drug Court Grad Brings More Life to Drug Court Program 2Health News:Drug Court Grad Brings More Life to Drug Court Program 3Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 2Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 3Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 4Health News:Advanced Hair Loss Patients Can Now Qualify for Hair Transplants Using Facial Donor Hair 2Health News:Charleston SC Audiologist, Dr. Mary Ann Larkin Authors Four New Special Reports on Important Hearing Healthcare Topics 2Health News:Charleston SC Audiologist, Dr. Mary Ann Larkin Authors Four New Special Reports on Important Hearing Healthcare Topics 3Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 2Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 3
... If you want to provide poor people in developing countries ... at the same time. That is the conclusion of researcher ... and on his experience in several other low- and mid-income ... important role, but the authorities also have a role to ...
... the Sept. 29, 2011, edition of the New England ... nursing home residents with advanced dementia experiences burdensome transitions in ... a different facility in the last three days of life ... last 90 days of life. "Such patterns of transitions ...
... -- Cancer patients are often faced with many difficult-to-understand ... even mean the difference between life and death. ... use plain language in explaining the options, advised ... the University of Michigan Medical School and a researcher ...
... By Amanda Gardner HealthDay Reporter , WEDNESDAY, ... illness connected to listeria-tainted cantaloupes has now infected 72 people ... said Wednesday, making it the deadliest such outbreak in more ... eight states, including two in Colorado, one in Kansas, one ...
... and the National Partnership for Women & Families joined ... Services on the announcement of the new Comprehensive Primary ... that the Comprehensive Primary Care Initiative offers enormous potential ... that patients seek and that physicians want to deliver," ...
... STANFORD, Calif. -- Researchers at the Stanford University School ... that the brain activation patterns in children with poor ... those in poor readers with a typical IQ. The ... similar kinds of difficulties regardless of their general cognitive ...
Cached Medicine News:Health News:How do you bring health care to the poor? 2Health News:Dementia patients face burdensome transitions in last 90 days 2Health News:Dementia patients face burdensome transitions in last 90 days 3Health News:Cancer Patients Should Ask Doctors to Use Simple Terms 2Health News:Listeria Outbreak Is Deadliest in More Than a Decade 2Health News:Listeria Outbreak Is Deadliest in More Than a Decade 3Health News:Consumers and physicians together applaud Comprehensive Primary Care Initiative 2Health News:Stanford brain imaging study shows physiological basis of dyslexia 2Health News:Stanford brain imaging study shows physiological basis of dyslexia 3
(Date:8/29/2014)... 2014 Diseases largely eradicated in ... returning. Measles was declared eliminated in 2000, yet the ... August 15—the highest incidence in 20 years. In July, ... whooping cough a problem of "epidemic proportions." ... dying from these preventable diseases—in part because some parents ...
(Date:8/29/2014)...  Abaxis, Inc. (NasdaqGS: ABAX ), a ... to the medical, research and veterinary markets, announced today ... Officer, will present at the CL King 12 th ... 9, 2014 at 12:30 p.m. ET. The conference will ... New York City . ...
(Date:8/29/2014)... , August 29, 2014 ... participate in the inaugural Tweetchat taking place in ... Worldwide , organised by UBM Live , ... #CPhIChat is a first of its kind global ... across the supply chain, aimed to stimulate conversations ...
Breaking Medicine Technology:Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 3
... WIRE)--Jun 28, 2007 - CombinatoRx,Incorporated (NASDAQ: CRXX) ... placebo-controlled clinical trial of,CRx-150 in patients with ... a disease-modifying anti-rheumatic drug,(DMARD) to placebo plus ... the preliminary analysis of this trial, CRx-150 ...
... percent response rate achieved with VELCADE, lenalidomide,and ... -- Millennium,Pharmaceuticals, Inc. (Nasdaq: MLNM) today reported ... trials of VELCADE based,therapies that showed consistently ... (CR) rates in newly diagnosed,multiple myeloma (MM) ...
Cached Medicine Technology:CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and,Pain, but Not CRP 2CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and,Pain, but Not CRP 3CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and,Pain, but Not CRP 4CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and,Pain, but Not CRP 5Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 2Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 3Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 4Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 5Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 6Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 7Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 8
...
Enables Delicate Lifting Of The Flap Without Causing Trauma - Also available in Titanium...
Khosla Precision and Quality in Medical and Surgical Products....
The CGVL vitrectomy contact glass was designed by Rol, Fankhauser et al. for photodisruptive YAG laser procedures in the posterior vitreous....
Medicine Products: